Opinion: Cannabis companies should file amended tax returns to claim 280E refunds
Two legal cases have realistic chances of success, meaning cannabis operators should consider filing amended federal tax returns claiming refunds.
Two legal cases have realistic chances of success, meaning cannabis operators should consider filing amended federal tax returns claiming refunds.
U.S. Department of Justice attorneys asked a federal judge on Tuesday to dismiss a lawsuit filed by four marijuana companies challenging federal prohibition.
Here’s how marijuana rescheduling could impact medical practitioners working in the cannabis space.
The Biden administration’s push to reclassify marijuana under federal law would not by itself open the door for pharmaceutical companies to seize control of the $34 billion legal U.S. cannabis industry.
State-regulated medical cannabis programs and illicit users are at least in part to thank for the Biden administration’s recommendation that marijuana be moved from Schedule 1 to Schedule 3 of the Controlled Substances Act.
The Biden administration on late Friday released the unredacted exchange between federal authorities recommending marijuana be rescheduled.
Attorneys general from 12 states sent a letter to the head of the U.S. Drug Enforcement Administration to “encourage” the DEA to reschedule marijuana.
From legislative and regulatory changes to market sensitivity and price stabilization to M&A dynamics, it will be crucial to remain cautious of hurdles that the marijuana sector will face and stay on top of the five areas that are expected to shape the industry in 2024.
The U.S. Drug Enforcement Administration is currently “conducting its review” of an earlier recommendation that the agency reschedule marijuana, a DEA official recently told a federal lawmaker.
MJBizDaily offers up seven predictions for the U.S. cannabis industry in 2024, including the rescheduling of marijuana.
Here are eight predictions for trends that could most likely impact state-regulated marijuana markets in 2024.
A letter from California Attorney General Rob Bonta to state regulators all but ended marijuana industry hopes of interstate cannabis commerce.